At the annual meeting on April 21, 2025, stockholders elected six directors, ratified Baker Tilly as auditors, approved a warrant share issuance, and authorized a reverse stock split to comply with Nasdaq requirements.
AI Assistant
HELIUS MEDICAL TECHNOLOGIES INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.